Table 3.
Results of verification of occupational disease-specific biomarkers
| Name | Disease | Direct evidencea | Inference score | Number of references |
|---|---|---|---|---|
| AHR | Breast neoplasms | M | 134.87 | 404 |
| BCL2 | Breast neoplasms | M | 307.33 | 742 |
| PARP1 | Breast neoplasms | M | 285 | 701 |
| TNF | Breast neoplasms | M | 254.24 | 755 |
| AKT1 | Breast neoplasms | M | 250.16 | 704 |
| CASP8 | Breast neoplasms | M | 244.74 | 680 |
| IFNG | Breast neoplasms | M | 217.06 | 619 |
| SOD2 | Breast neoplasms | M | 213.22 | 691 |
| CXCL8 | Breast neoplasms | M | 208.81 | 604 |
| NFKBIA | Breast neoplasms | M | 204.82 | 647 |
| CAT | Breast neoplasms | M | 198.96 | 658 |
| GSTP1 | Breast neoplasms | M | 179.83 | 610 |
aDirect evidence “M”: this means a direct evidence for diagnostic markers in the CTD DB